{"id":"https://openalex.org/W1991745909","doi":"https://doi.org/10.1158/0008-5472.sabcs13-ot3-2-07","title":"Abstract OT3-2-07: Phase I study of ARN-810, a novel selective estrogen receptor degrader, in post-menopausal women with locally advanced or metastatic estrogen receptor positive breast cancer","display_name":"Abstract OT3-2-07: Phase I study of ARN-810, a novel selective estrogen receptor degrader, in post-menopausal women with locally advanced or metastatic estrogen receptor positive breast cancer","publication_year":2013,"publication_date":"2013-12-15","ids":{"openalex":"https://openalex.org/W1991745909","doi":"https://doi.org/10.1158/0008-5472.sabcs13-ot3-2-07","mag":"1991745909"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.sabcs13-ot3-2-07","doi":"https://doi.org/10.1158/0008-5472.sabcs13-ot3-2-07","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs13-ot3-2-07","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081741406","display_name":"Ingrid A. Mayer","orcid":"https://orcid.org/0000-0001-8147-335X","observed_orcids":["https://orcid.org/0000-0001-8147-335X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"IA Mayer","raw_affiliation_strings":["Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","Aragon Pharmaceuticals, San Diego, CA","Massachusetts General Hospital, Boston, MA","Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Aragon Pharmaceuticals, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034972183","display_name":"Aditya Bardia","orcid":"https://orcid.org/0000-0003-4885-1157","observed_orcids":["https://orcid.org/0000-0003-4885-1157"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Bardia","raw_affiliation_strings":["Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","Aragon Pharmaceuticals, San Diego, CA","Massachusetts General Hospital, Boston, MA","Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Aragon Pharmaceuticals, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069795948","display_name":"Maura N. Dickler","orcid":"https://orcid.org/0000-0003-4631-6572","observed_orcids":["https://orcid.org/0000-0003-4631-6572"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MN Dickler","raw_affiliation_strings":["Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","Aragon Pharmaceuticals, San Diego, CA","Massachusetts General Hospital, Boston, MA","Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Aragon Pharmaceuticals, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028063270","display_name":"H. Charles Manning","orcid":"https://orcid.org/0000-0002-5057-4518","observed_orcids":["https://orcid.org/0000-0002-5057-4518","https://orcid.org/0000-0002-2042-8800"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"HC Manning","raw_affiliation_strings":["Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","Aragon Pharmaceuticals, San Diego, CA","Massachusetts General Hospital, Boston, MA","Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Aragon Pharmaceuticals, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063494562","display_name":"Umar Mahmood","orcid":"https://orcid.org/0000-0001-7414-6123","observed_orcids":["https://orcid.org/0000-0001-7414-6123"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"U Mahmood","raw_affiliation_strings":["Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","Aragon Pharmaceuticals, San Diego, CA","Massachusetts General Hospital, Boston, MA","Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Aragon Pharmaceuticals, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024743507","display_name":"Gary A. Ulaner","orcid":"https://orcid.org/0000-0002-7953-0113","observed_orcids":["https://orcid.org/0000-0002-7953-0113"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"GA Ulaner","raw_affiliation_strings":["Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","Aragon Pharmaceuticals, San Diego, CA","Massachusetts General Hospital, Boston, MA","Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Aragon Pharmaceuticals, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033889507","display_name":"Jeff Hager","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JH Hager","raw_affiliation_strings":["Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","Aragon Pharmaceuticals, San Diego, CA","Massachusetts General Hospital, Boston, MA","Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Aragon Pharmaceuticals, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077906047","display_name":"Peter J. Rix","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P Rix","raw_affiliation_strings":["Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","Aragon Pharmaceuticals, San Diego, CA","Massachusetts General Hospital, Boston, MA","Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Aragon Pharmaceuticals, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006255616","display_name":"N Zack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N Zack","raw_affiliation_strings":["Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","Aragon Pharmaceuticals, San Diego, CA","Massachusetts General Hospital, Boston, MA","Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Aragon Pharmaceuticals, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052412854","display_name":"EC Maneval","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"EC Maneval","raw_affiliation_strings":["Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","Aragon Pharmaceuticals, San Diego, CA","Massachusetts General Hospital, Boston, MA","Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Aragon Pharmaceuticals, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046425910","display_name":"I Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I Chen","raw_affiliation_strings":["Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","Aragon Pharmaceuticals, San Diego, CA","Massachusetts General Hospital, Boston, MA","Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Aragon Pharmaceuticals, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Baselga","raw_affiliation_strings":["Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","Aragon Pharmaceuticals, San Diego, CA","Massachusetts General Hospital, Boston, MA","Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Aragon Pharmaceuticals, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012305640","display_name":"CL Arteaga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"CL Arteaga","raw_affiliation_strings":["Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","Aragon Pharmaceuticals, San Diego, CA","Massachusetts General Hospital, Boston, MA","Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Massachusetts General Hospital, Boston, MA; Memorial Sloan-Kettering Cancer Center, New York, NY; Aragon Pharmaceuticals, San Diego, CA","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"raw_affiliation_string":"Aragon Pharmaceuticals, San Diego, CA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I4390039299","https://openalex.org/I901861585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"24_Supplement","first_page":"OT3","last_page":"2"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.5898000001907349,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.5898000001907349,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.31540000438690186,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.08340000361204147,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selective-estrogen-receptor-degrader","display_name":"selective estrogen receptor degrader","score":0.9649999737739563},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.9459999799728394},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.8830000162124634},{"id":"https://openalex.org/keywords/tamoxifen-resistance","display_name":"tamoxifen resistance","score":0.7580000162124634},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.8539999723434448},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7020000219345093},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.875},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8610000014305115},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.6949999928474426},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.984000027179718},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.6669999957084656}],"concepts":[{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.8388307094573975},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.8085664510726929},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7044312357902527},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6489913463592529},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.6214372515678406},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5457625985145569},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5331569910049438},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4801044762134552},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.44825315475463867},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.413544237613678},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38961708545684814}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.sabcs13-ot3-2-07","doi":"https://doi.org/10.1158/0008-5472.sabcs13-ot3-2-07","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs13-ot3-2-07","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2342941820","https://openalex.org/W2563294220","https://openalex.org/W2340954305","https://openalex.org/W2012767871","https://openalex.org/W4309391099","https://openalex.org/W2323968754","https://openalex.org/W2407256050","https://openalex.org/W2486013003","https://openalex.org/W2138154153","https://openalex.org/W2060004930"],"abstract_inverted_index":{"Abstract":[0,466],"Background:":[1],"Modulation":[2],"of":[3,13,54,69,77,90,148,164,176,187,191,198,227,270,349,358,360,438],"estrogen":[4,19],"synthesis":[5],"or":[6,241,254,285],"its":[7],"receptor":[8,71],"activity":[9,397],"represents":[10],"the":[11,52,70,122,173,199,222,264,282,345,411,421,427,436],"treatment":[12,177,390],"choice":[14],"for":[15,326,420],"postmenopausal":[16,236],"women":[17,237],"with":[18,105,158,224,230,238,272,288,312,364,375],"receptor-positive":[20],"(ER+)":[21],"breast":[22,93],"cancer":[23,94],"(BC).":[24],"However,":[25],"despite":[26],"initial":[27],"response":[28,125,363],"to":[29,126,135,184,315,324,343,353,386],"hormonal":[30,278],"manipulation,":[31],"most":[32],"tumors":[33],"ultimately":[34],"develop":[35],"endocrine":[36],"resistance.":[37],"The":[38,162,214,339,417],"emerging":[39],"evidence":[40],"that":[41,56,86],"ER\u03b1":[42,61,84,91],"can":[43,453],"signal":[44],"in":[45,92,113,121,172,189,281,410],"both":[46,75,114],"ligand-dependent":[47],"and":[48,72,116,131,145,249,258,298,308,320,332,355,366,393,399,430],"independent":[49],"manner":[50],"supports":[51],"development":[53],"agents":[55],"are":[57,261],"not":[58],"only":[59],"competitive":[60],"antagonists":[62],"but":[63],"also":[64],"reduce":[65],"steady":[66],"state":[67],"levels":[68],"thus":[73],"limit":[74],"modes":[76],"signaling.":[78],"ARN-810":[79,149,188],"is":[80,142,342],"a":[81,143,153,159],"novel,":[82],"non-steroidal":[83],"antagonist":[85],"induces":[87],"proteasomal-mediated":[88],"degradation":[89],"cell":[95],"lines":[96],"at":[97,299,414,456],"picomolar":[98],"concentrations.":[99],"This":[100,141],"unique":[101],"biological":[102],"profile":[103],"coupled":[104],"good":[106],"oral":[107],"pharmacokinetics":[108],"(PK)":[109],"produced":[110],"tumor":[111,136,317,322],"regression":[112],"tamoxifen-sensitive":[115],"resistant":[117],"BC":[118],"models.":[119],"Importantly,":[120],"tamoxifen-resistant":[123],"model,":[124],"ER":[127,318,327,367],"modulators":[128],"like":[129],"fulvestrant":[130,289],"tamoxifen":[132],"was":[133],"limited":[134],"growth":[137],"arrest.":[138],"Trial":[139],"Design:":[140],"safety":[144,354,392,429],"PK":[146,160,294,394],"study":[147,452],"administered":[150],"orally":[151],"on":[152],"continuous":[154],"daily":[155],"dosing":[156],"regimen":[157],"lead-in.":[161],"incidence":[163],"dose":[165,195,202,223,297,422,441],"limiting":[166],"toxicity":[167],"(DLT)":[168],"will":[169,181,218,290,301,335,371,383,424,434,445],"be":[170,182,219,291,302,336,372,384,446,454],"assessed":[171],"first":[174,296,412],"cycle":[175],"(28":[178],"days).":[179],"Patients":[180],"assigned":[183],"escalating":[185],"doses":[186],"cohorts":[190,269],"3-6":[192],"patients":[193,229,271,406,444],"per":[194],"until":[196],"determination":[197],"maximum":[200],"tolerated":[201],"(MTD)":[203],"and/or":[204,216,266,347],"recommended":[205],"Phase":[206],"2":[207],"Dose":[208],"(RP2D)":[209],"using":[210,304],"standard":[211],"3+3":[212],"criteria.":[213],"MTD":[215,265,346],"RP2D":[217,348],"defined":[220],"as":[221],"\u22641":[225],"out":[226],"6":[228],"DLT.":[231],"Key":[232],"eligibility":[233],"criteria":[234],"include":[235],"locally":[239],"advanced":[240],"metastatic":[242,283],"ER+":[243],"(HER2-)":[244],"BC,":[245],"ECOG":[246],"PS":[247],"0/1,":[248],"adequate":[250],"organ":[251],"function.":[252],"Untreated":[253],"symptomatic":[255],"brain":[256],"metastases":[257],"endometrial":[259],"disorders":[260],"exclusionary.":[262],"At":[263],"RP2D,":[267],"expansion":[268],"disease":[273],"progression":[274],"after":[275,295],"\u22642":[276],"prior":[277,286],"therapies":[279],"(\u22641":[280],"setting)":[284],"therapy":[287],"enrolled.":[292,447],"Plasma":[293],"steady-state":[300],"analyzed":[303],"non-compartmental":[305],"methods.":[306],"Pre-":[307],"post-treatment":[309],"functional":[310],"imaging":[311],"[18F]-fluoroestradiol":[313],"(FES)-PET":[314],"assess":[316,325],"binding":[319],"paired":[321],"biopsies":[323],"target":[328,368,418],"modulation":[329],"by":[330],"IHC":[331],"gene":[333,369],"expression":[334,370],"performed.":[337],"Objectives:":[338],"primary":[340],"objective":[341],"determine":[344,435],"ARN-810.":[350,459],"In":[351],"addition":[352],"PK,":[356],"evaluation":[357],"biomarkers":[359],"pharmacodynamic":[361],"(PD)":[362],"FES-PET":[365],"explored":[373],"along":[374],"preliminary":[376],"antitumor":[377,396],"activity.":[378],"Statistical":[379],"Methods:":[380],"Descriptive":[381],"statistics":[382],"used":[385],"summarize":[387],"patient":[388],"characteristics,":[389],"administration/compliance,":[391],"parameters,":[395],"endpoints,":[398],"exploratory":[400],"biomarkers.":[401],"Status:":[402],"To":[403],"date,":[404],"3":[405],"have":[407],"been":[408],"enrolled":[409],"cohort":[413],"100":[415],"mg/day.":[416],"accrual":[419],"escalation":[423],"depend":[425],"upon":[426],"observed":[428],"PK/PD":[431],"profile,":[432],"which":[433],"number":[437],"escalations.":[439],"During":[440],"expansion,":[442],"30":[443],"More":[448],"information":[449],"about":[450],"this":[451],"found":[455],"http://clinicaltrials.gov/ct2/show/NCT01823835?term":[457],"=":[458],"Citation":[460],"Information:":[461],"Cancer":[462],"Res":[463],"2013;73(24":[464],"Suppl):":[465],"nr":[467],"OT3-2-07.":[468]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}